BACKGROUND: Musculoskeletal symptoms owned by the spectral range of seronegative spondyloarthritis (SpA) will be the most common extraintestinal manifestations in sufferers with inflammatory colon disease (IBD) and could lead to essential disease burden. diagnosed in 18 (27.3%) sufferers, peripheral SpA in 20 (30.3%) sufferers and another rheumatic disorder in 14 (21.2%) sufferers. Bottom line: Musculoskeletal… Continue reading BACKGROUND: Musculoskeletal symptoms owned by the spectral range of seronegative spondyloarthritis